Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $8.7950 (0.86%) ($8.7950 - $8.7950) on Thu. Jun. 1, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.34% (three month average) | RSI | 63 | Latest Price | $8.7950(0.86%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 1.6% a day on average for past five trading days. | Weekly Trend | IOVA advances 5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) XBI(32%) ACES(28%) IBB(21%) BLOK(20%) GLD(20%) | Factors Impacting IOVA price | IOVA will decline at least -2.67% in a week (0% probabilities). XLU(-21%) XLP(-21%) UUP(-17%) SPLV(-17%) USO(-15%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.67% (StdDev 5.34%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.33(5.58%) | 10 Day Moving Average | $8.19(7.39%) | 20 Day Moving Average | $7.79(12.9%) | To recent high | -3.4% | To recent low | 63.9% | Market Cap | $1.288b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |